Institutional Ownership
Cadrenal Therapeutics Inc
CUSIP 127636207COM NEWCVKDQ1 2026
Institutional Holders
15
13F filers
Shares Held
37.4K
Aggregate institutional
Institutional Value
$177.5K
Q1 2026
Net New Holders
-2
3 new · 5 closed
Institutional Ownership Trend
Aggregate 13F value by quarter
Multi-quarter trend — upgrade to see history
UpgradePosition Activity
Q1 2026
New positions3
Increased2
Decreased5
Sold out5
Institutional Holders
15 funds hold this security · Q1 2026
| # | Fund | Shares | Value | Δ Shares | Activity |
|---|---|---|---|---|---|
| 1 | Geode Capital Management, LLC | 21.6K | $110.7K | +7.1K | Added |
| 2 | Jpmorgan Chase & Co | 7.5K | $31.9K | 0 | Held |
| 3 | Blackrock, Inc. | 5.5K | $28.1K | +2.0K | Added |
| 4 | Tower Research Capital LLC (Trc) | 393 | $2.0K | −139 | Reduced |
| 5 | Osaic Holdings, Inc. | 300 | $1.5K | −200 | Reduced |
| 6 | Destiny Wealth Partners, LLC | 200 | $1.0K | +200 | New |
| 7 | Rockefeller Capital Management L.P. | 150 | $768 | −150 | Reduced |
| 8 | Morgan Stanley | 100 | $512 | −980 | Reduced |
| 9 | Wells Fargo & Company/Mn | 99 | $507 | 0 | Held |
| 10 | Archer Investment Corp | 35 | $179 | 0 | Held |
5 more institutional holders on Premium
See every fund holding Cadrenal Therapeutics Inc, with full quarter-over-quarter share changes.
Unlock all holders